S. Attardo

Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma

Giuseppe Cabibbo, Salvatore Petta, Marco Barbàra et al. · Journal of Hepatology · 2017 · 111 citations · Full text

Medicine, Infectious Diseases, Hepatology +14

Refining prognosis after trans‐arterial chemo‐embolization for hepatocellular carcinoma

Alberta Cappelli, Alessandro Cucchetti, Giuseppe Cabibbo et al. · Liver International · 2015 · 85 citations

Medicine, Oncology, Surgery +16

Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of <scp>HCV</scp> eradication does not depend on the use of interferon

Giuseppe Cabibbo, Marco Barbàra, S. Attardo et al. · Alimentary Pharmacology & Therapeutics · 2016 · 79 citations · Full text

Medicine, Oncology, Hepatic Pharmacotherapy +16

Changes in digestive cancer diagnosis during the SARS-CoV-2 pandemic in Italy: A nationwide survey

Elisabetta Buscarini, A. Benedetti, Fabio Monica et al. · Digestive and Liver Disease · 2021 · 37 citations · Full text

Medicine, Infectious Diseases, Oncology +16

Survival of Patients with Hepatocellular Carcinoma (HCC) Treated by Percutaneous Radio-Frequency Ablation (RFA) Is Affected by Complete Radiological Response

Giuseppe Cabibbo, Marcello Maida, Chiara Genco et al. · PLoS ONE · 2013 · 36 citations · Full text

Medicine, Oncology, Radiology +17